Osteoporosis post-menopausal and Hair texture abnormal
Summary:
Hair texture abnormal is found among people with Osteoporosis post-menopausal, especially for people who are female, 60+ old.
The study analyzes which people have Hair texture abnormal with Osteoporosis post-menopausal. It is created by eHealthMe based on reports of 22 people who have Osteoporosis post-menopausal from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Osteoporosis post-menopausal?
Osteoporosis post-menopausal (weak bone with possibility to break after stopped menstrual cycles) is found to be associated with 42 drugs and 109 conditions by eHealthMe. Check the latest studies of Osteoporosis post-menopausal.
What is Hair texture abnormal?
Hair texture abnormal is found to be associated with 729 drugs and 655 conditions by eHealthMe. Check the latest studies of Hair texture abnormal.
22 people who have Osteoporosis Post-Menopausal and Hair Texture Abnormal are studied.

Gender of people who have Osteoporosis Post-Menopausal and experienced Hair Texture Abnormal *:
- female: 100 %
- male: 0.0 %
Age of people who have Osteoporosis Post-Menopausal and experienced Hair Texture Abnormal *:
- 0-1: 5.5600000000000005 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 11.11 %
- 60+: 83.33 %
Common co-existing conditions for these people *:
- Neuropathy Peripheral (surface nerve damage): 2 people, 9.09%
- Joint Pain: 2 people, 9.09%
- Bone Pain: 2 people, 9.09%
- Hypotonia (low muscle tone): 1 person, 4.55%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.55%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.55%
- Cardiac Disorder: 1 person, 4.55%
Common drugs taken by these people *:
- Prolia: 20 people, 90.91%
- Calcium: 4 people, 18.18%
- Vitamin D3: 3 people, 13.64%
- Vitamin D: 3 people, 13.64%
- Requip: 2 people, 9.09%
- Omeprazole: 2 people, 9.09%
- Lyrica: 2 people, 9.09%
- Synthroid: 2 people, 9.09%
- Tymlos: 2 people, 9.09%
- Aspirin: 1 person, 4.55%
Common symptoms for these people *:
- Hair Loss: 7 people, 31.82%
- Dry Skin: 7 people, 31.82%
- Feeling Abnormal: 5 people, 22.73%
- Fatigue (feeling of tiredness): 5 people, 22.73%
- Muscle Aches (muscle pain): 5 people, 22.73%
- Joint Pain: 5 people, 22.73%
- Pain: 4 people, 18.18%
- Pain In Extremity: 4 people, 18.18%
- Bone Pain: 3 people, 13.64%
- Memory Loss: 3 people, 13.64%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Hair texture abnormal?
- Check whether Hair texture abnormal is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Osteoporosis post-menopausal (42,211 reports)
- Hair texture abnormal (18,699 reports)
All the drugs that are associated with Hair texture abnormal:
- Hair texture abnormal (729 drugs)
All the conditions that are associated with Hair texture abnormal:
- Hair texture abnormal (655 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Hair texture abnormal and Osteoporosis post-menopausal, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Pantoprazole and Ampicillin Sodium - now
- Drug interactions of Bethkis and Ceftazidime - 4 seconds ago
- Drug interactions of Sertraline Hydrochloride and Latuda - 10 seconds ago
- Could Metformin cause Appetite Disorder? - 10 seconds ago
- How effective is Effexor for Fibromyalgia? - 14 seconds ago
- Drug interactions of Ezetimibe and Rosiglitazone Maleate - 24 seconds ago
- Drug interactions of Robaxin-750 and Hydrocodone Bitartrate And Acetaminophen - 25 seconds ago
- Could Daliresp cause Appetite Decreased? - 27 seconds ago
- Could Daliresp cause Appetite - Decreased? - 28 seconds ago
- Lower Respiratory Tract Infection and Nausea And Vomiting - 38 seconds ago